Notification
No new Notification messages
Afcons Infrastructure IPO is Open!
Apply for the Afcons Infrastructure IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Diwali Offer: MTF at just 9.99%
Iss Diwali, Investments Ko Karo 4X with our Trade Now, Pay Later (MTF) feature
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
vaishali pharma limited stock

VAISHALI PHARMA LIMITED Share Price

18.47 -0.15 (-0.80%)
Oct 25 2024 03:29 PM [-] NSE: VAISHALI

VAISHALI PHARMA LIMITED Share Price Update

As of the latest trading session, VAISHALI PHARMA LIMITED share price is currently at 18.47, which is down by -0.15 from its previous closing. Today, the stock has fluctuated between 17.80 and 19.48. Over the past year, VAISHALI PHARMA LIMITED has achieved a return of 0.0 %. In the last month alone, the return has been 0.0 %. Read More...

VAISHALI PHARMA LIMITED Performance

Day Range

Low17.80 High19.48
.00

52 Week Range

Low 12.49 High 24.91
.00

VAISHALI PHARMA LIMITED Share Price

16621

VAISHALI

img img img img
No Data Available

Open Price

17.80

Prev. Close

18.63

Volume (Shares)

.00

Total traded value

.00

Upper Circuit

19.56

Lower Circuit

17.69

Note: The current prices & values are delayed, Login to your account for live updates.

VAISHALI PHARMA LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 0.0
PE Ratio (TTM) 0.0
Book Value / Share 0.0
Beta 0.0
ROE 0.0%
EPS (TTM) 0.0
Dividend Yield 0.0%
Net Profit Qtr (Cr) 0.0

VAISHALI PHARMA LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 18.08
Operating Expense 16.24
Net Profit 1.70
Net Profit Margin (%) 9.40
Earnings Per Share (EPS) 1.48
EBITDA 2.77
Effective Tax Rate (%) 25.11
Particulars MAR 2024 (Values in Cr)
Revenue 32.40
Operating Expense 39.72
Net Profit -4.68
Net Profit Margin (%) -14.44
Earnings Per Share (EPS) -4.37
EBITDA -5.88
Effective Tax Rate (%) 26.94
Particulars DEC 2023 (Values in Cr)
Revenue 27.90
Operating Expense 25.50
Net Profit 2.11
Net Profit Margin (%) 7.56
Earnings Per Share (EPS) 1.99
EBITDA 3.41
Effective Tax Rate (%) 26.22
Particulars SEP 2023 (Values in Cr)
Revenue 12.57
Operating Expense 10.50
Net Profit 1.70
Net Profit Margin (%) 13.52
Earnings Per Share (EPS) 1.61
EBITDA 2.95
Effective Tax Rate (%) 27.96
Particulars JUN 2023 (Values in Cr)
Revenue 13.42
Operating Expense 11.66
Net Profit 1.59
Net Profit Margin (%) 11.84
Earnings Per Share (EPS) 1.50
EBITDA 2.67
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 86.28
Operating Expense 87.39
Net Profit 0.72
Net Profit Margin (%) 0.83
Earnings Per Share (EPS) 0.67
EBITDA 3.17
Effective Tax Rate (%) 22.58
Particulars MAR 2023 (Values in Cr)
Revenue 69.66
Operating Expense 63.05
Net Profit 6.60
Net Profit Margin (%) 9.47
Earnings Per Share (EPS) 6.26
EBITDA 11.36
Effective Tax Rate (%) 25.31
Particulars MAR 2022 (Values in Cr)
Revenue 75.82
Operating Expense 71.88
Net Profit 4.02
Net Profit Margin (%) 5.30
Earnings Per Share (EPS) 3.82
EBITDA 8.65
Effective Tax Rate (%) 29.66
Particulars MAR 2021 (Values in Cr)
Revenue 52.31
Operating Expense 54.18
Net Profit 1.05
Net Profit Margin (%) 2.00
Earnings Per Share (EPS) 0.99
EBITDA 4.43
Effective Tax Rate (%) 25.71
Particulars MAR 2020 (Values in Cr)
Revenue 59.52
Operating Expense 62.18
Net Profit 0.03
Net Profit Margin (%) 0.05
Earnings Per Share (EPS) 0.03
EBITDA 3.00
Effective Tax Rate (%) 62.50
Particulars MAR 2024 (Values in Cr)
Book Value / Share 39.97
ROE % 1.73
ROCE % 5.71
Total Debt to Total Equity 0.34
EBITDA Margin 4.29
Particulars MAR 2023 (Values in Cr)
Book Value / Share 38.43
ROE % 19.73
ROCE % 21.59
Total Debt to Total Equity 0.53
EBITDA Margin 16.67
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.99
ROE % 16.48
ROCE % 18.70
Total Debt to Total Equity 0.79
EBITDA Margin 11.43
Particulars MAR 2021 (Values in Cr)
Book Value / Share 21.26
ROE % 4.79
ROCE % 10.23
Total Debt to Total Equity 0.80
EBITDA Margin 8.29
Particulars MAR 2020 (Values in Cr)
Book Value / Share 20.27
ROE % 0.14
ROCE % 6.84
Total Debt to Total Equity 0.80
EBITDA Margin 5.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.57
Total Assets 79.95
Total Liabilities 79.95
Total Equity 42.83
Share Outstanding 10719213
Price to Book Ratio 3.50
Return on Assets (%) 0.89
Return on Capital (%) 1.3
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.98
Total Assets 78.89
Total Liabilities 78.89
Total Equity 40.53
Share Outstanding 10546213
Price to Book Ratio 3.80
Return on Assets (%) 8.36
Return on Capital (%) 12.18
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.35
Total Assets 81.62
Total Liabilities 81.62
Total Equity 26.35
Share Outstanding 10546213
Price to Book Ratio 2.65
Return on Assets (%) 4.92
Return on Capital (%) 8.54
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 86.12
Total Liabilities 86.12
Total Equity 22.41
Share Outstanding 10546213
Price to Book Ratio 1.53
Return on Assets (%) 1.21
Return on Capital (%) 2.62
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.37
Total Assets 66.20
Total Liabilities 66.20
Total Equity 21.38
Share Outstanding 10546213
Price to Book Ratio 1.98
Return on Assets (%) 0.04
Return on Capital (%) 0.09
Particulars MAR 2024 (Values in Cr)
Net Income 0.92
Cash from Operations 3.08
Cash from Investing 1.20
Cash from Financing -1.41
Net change in Cash 0.59
Free Cash Flow 3.19
Particulars MAR 2023 (Values in Cr)
Net Income 8.84
Cash from Operations 2.64
Cash from Investing 0.28
Cash from Financing -1.73
Net change in Cash -0.37
Free Cash Flow 2.94
Particulars MAR 2022 (Values in Cr)
Net Income 5.72
Cash from Operations 2.14
Cash from Investing -0.84
Cash from Financing 0.41
Net change in Cash 0.88
Free Cash Flow 3.01
Particulars MAR 2021 (Values in Cr)
Net Income 1.40
Cash from Operations 2.07
Cash from Investing -0.11
Cash from Financing -1.81
Net change in Cash 0.08
Free Cash Flow 2.20
Particulars MAR 2020 (Values in Cr)
Net Income 0.07
Cash from Operations 3.94
Cash from Investing -0.01
Cash from Financing -3.13
Net change in Cash 0.06
Free Cash Flow 3.99
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 731.10 43.88 6.58 25661.61 280.00 / 969.95
Aegis Logistics Ltd 34.29 1.57 -6.07 65.53 1.80 / 34.29
Aegis Logistics Ltd 218.85 35.76 0.65 144.08 127.20 / 261.90
OSWAL AGRO MILLS LTD 76.68 255.60 1.22 1029.28 29.30 / 93.95
STANDARD INDUSTRIES LTD. 26.75 133.75 1.26 172.08 20.23 / 38.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 731.10 51.02 10.77 25661.61 280.00 / 969.95
Vaishali Pharma Ltd 6.52 0.00 0.58 19.56 3.70 / 11.63
Vaishali Pharma Ltd 34.29 1.57 -6.08 65.53 1.80 / 34.29
Vaishali Pharma Ltd 65.68 0.00 -37.10 5.98 55.30 / 96.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 21.40
  • 26 Days 20.10
  • 10 Days 20.80
  • 50 Days 19.00
  • 12 Days 20.70
  • 100 Days 17.80
  • 20 Days 20.30
  • 200 Days 17.70
20.69
PIVOT
First Resistance 21.59
Second Resistance 23.09
Third Resistance 23.99
First Support 19.19
Second Support 18.29
Third Support 16.79
RSI 52.46
MACD 0.54
Commodity Channel Index (CCI) 49.15
ADX 18.67
Williams % R -64.49

Over 1 Month

down

0.0

Over 3 Months

down

0.0

Over 6 Months

down

0.0

Over 1 Year

down

0.0

Over 3 Years

down

0.0

Over 5 Years

down

0.0

VAISHALI PHARMA LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

VAISHALI PHARMA LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
0.0
Promoter Holdings
0.0
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%

VAISHALI PHARMA LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
2024-10-15 2024-10-15 1:1 2019-10-18 2019-10-17 3:5
Ex-Date Old FV NEW FV Record Date
2024-10-15 10.0 2.0 2024-10-15

Learn More About Stocks

About VAISHALI PHARMA LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by VAISHALI PHARMA LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Vaishali Pharma Ltd?

Answer Field

The share price of Vaishali Pharma Ltd for NSE is ₹ 18.47 and for BSE is ₹ 0.00.

What is the Market Cap of Vaishali Pharma Ltd?

Answer Field

The market cap of Vaishali Pharma Ltd for NSE is ₹ 1,97.56 Cr. and for BSE is ₹ 0.00 Cr. as of now.

What is the 52 Week High and Low of Vaishali Pharma Ltd?

Answer Field

The 52 Week High and Low of Vaishali Pharma Ltd for NSE is ₹ 24.91 and ₹ 12.49 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Vaishali Pharma Ltd share?

Answer Field

You can trade in Vaishali Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vaishali Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 40.25%.

What is the Current Share Price of Vaishali Pharma Ltd?

Answer Field

Vaishali Pharma Ltd share price is for NSE ₹ 18.47 & for BSE ₹ 0.00 as on Oct 25 2024 03:29 PM.

What is the Market Cap of Vaishali Pharma Ltd Share?

Answer Field

The market cap of Vaishali Pharma Ltd for NSE ₹ 1,97.56 & for BSE ₹ 0.00 as on Oct 25 2024 03:29 PM.

What is the P/E Ratio of Vaishali Pharma Ltd Share?

Answer Field

As on Oct 25 2024 03:29 PM the price-to-earnings (PE) ratio for Vaishali Pharma Ltd share is 0.0.

What is the PB ratio of Vaishali Pharma Ltd Share?

Answer Field

As on Oct 25 2024 03:29 PM, the price-to-book (PB) ratio for Vaishali Pharma Ltd share is 0.0.

How to Buy Vaishali Pharma Ltd Share?

Answer Field

You can trade in Vaishali Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vaishali Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Vaishali Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vaishali Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader